Star Health and Allied Insurance Company (STARHEALTH) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
21 Oct, 2026Executive summary
FY 2023-24 delivered GWP of ₹15,254.45 crore, up 18% YoY, and PAT of ₹845.01 crore, up 37%; IFRS ROE was 17.7%.
Claims servicing remained a key operating strength: 1.75 million claims settled during the year, ₹89,136 million paid, and 94.8% of claims settled in under two hours.
Strategic priorities include profitable growth, digital-first services, improved product mix, wider distribution, technology investment and cost optimisation in FY 2024-25.
Financial highlights
GWP was ₹15,254.45 crore vs ₹12,952.47 crore in FY 2022-23; net earned premium was ₹12,938.27 crore vs ₹11,261.59 crore.
PAT rose to ₹845.01 crore from ₹618.59 crore; PBT reached ₹1,128.85 crore vs ₹826.40 crore.
Net claims incurred were ₹8,599.94 crore vs ₹7,320.40 crore; operating expenses were ₹2,394.42 crore vs ₹2,053.81 crore.
Investment income increased to ₹1,084.10 crore from ₹834.56 crore; investment assets were ₹15,490.89 crore vs ₹13,413.10 crore.
Net worth was ₹6,339.24 crore vs ₹5,430.13 crore; total assets were ₹17,767.74 crore vs ₹15,226.11 crore.
Outlook and guidance
FY 2024-25 priorities are growth with profitability, a digital-first ecosystem, better product mix, expanded distribution, technology investment and cost optimisation.
Plans include 1,000 Sales Manager Stations in remote locations during FY 2024-25; of 194 branches planned over five years, 153 are targeted for populations below one lakh.
India's health insurance market is projected to reach USD 30 billion by 2030; low penetration, particularly in rural areas, is viewed as a significant expansion opportunity.
Latest events from Star Health and Allied Insurance Company
- Market growth could not offset the sharp fall in government premium; losses narrowed.STARHEALTH
Q4 12/13 - Premiums grew 35%, but the FY2014-15 net loss widened to ₹14,005 lakh.STARHEALTH
Q4 14/15 - Premium growth and narrower losses supported a positive outlook focused on market business.STARHEALTH
Q4 13/14 - Premium growth and a profit turnaround came with a material URR adjustment and expense-limit overrun.STARHEALTH
Q4 15/16 - Premium growth accelerated, but profit and underwriting contribution weakened.STARHEALTH
Q4 16/17 - Gross premium rose to Rs 416,111 lakh as FY18 PAT reached Rs 17,015 lakh.STARHEALTH
Q4 17/18 - Premium growth and stronger underwriting lifted FY19 profit; solvency stood at 2.1.STARHEALTH
Q4 18/19 - Premium growth and higher profit came alongside rising claims ratios and pandemic uncertainty.STARHEALTH
Q4 19/20 - Premiums grew 37%, but reserve changes and claims drove a ₹1,085.71 crore loss.STARHEALTH
Q4 20/21